Clinical Trial Update: Safety and Efficacy of Ramelteon in Elderly Subjects With Chronic Insomnia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the safety and efficacy of ramelteon in elderly individuals with chronic insomnia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Insomnia

Drugs mentioned

• ROZEREM (ramelteon)
• Ramelteon (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Chronic Insomnia | Phase 3 | Status: COMPLETED